Skip to main navigation
  • About
    • About Us
    • Management Team
    • Board of Directors
    • Timeline
  • Pipeline
    • Overview
    • Hepatitis C Virus
    • Hepatitis B Virus
    • Respiratory Syncytial Virus
    • SARS-CoV-2
    • Human Metapneumovirus
  • Science
    • Overview
    • Publications
  • Patients
    • Overview
    • Clinical Trials
    • Expanded Access Policy
    • Resources
  • Careers
    • Join Us
    • Culture
    • Core Values
    • Testimonials
    • Benefits
  • Collaborations
    • Partnering
    • Out-Licensing
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
      • 2023 Annual Meeting
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Financials
      • Quarterly Results
      • Annual Reports
      • SEC Filings
    • ESG
      • Overview
      • Environmental
      • Social
      • Governance
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • RSS Feeds
  • Contact Us

Annual Reports

  • Overview
  • Press Releases
  • Events & Presentations
    • 2023 Annual Meeting Materials
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financials
    • Quarterly Results
    • Annual Reports
    • SEC Filings
  • ESG
    • Overview
    • Environmental
    • Social
    • Governance
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • RSS Feeds
2022 Annual Report
2022 Annual Report 8.4 MB
2021 Annual Report
2021 Annual Report 3.9 MB
2020 Annual Report
2020 Annual Report 4.1 MB
2019 Annual Report
2019 Annual Report 3.5 MB
2018 Annual Report
2018 Annual Report 1.4 MB
2017 Annual Report
2017 Annual Report 4.4 MB
2016 Annual Report
2016 Annual Report 2.1 MB
2015 Annual Report
2015 Annual Report 1.3 MB
2014 Annual Report
2014 Annual Report 812.1 KB
2013 Annual Report
2013 Annual Report 926.1 KB
  • Print Page Print Page
  • Email Alerts Email Alerts
  • RSS Feeds RSS Feeds
  • Contact IR Contact IR
enanta logo

©2023 Enanta Pharmaceuticals, Inc.

ENANTA PHARMACEUTICALS and accompanying logos are trademarks or registered trademarks of Enanta Pharmaceuticals, Inc.

Explore

  • About
  • Pipeline
  • Science
  • Patients
  • Careers
  • Collaborations
  • Investors
  • Contact Us

Contact

Enanta Pharmaceuticals, Inc. Headquarters
500 Arsenal Street
Watertown, MA 02472

(617) 607-0800
info@enanta.com

Legal

  • Privacy Policy
  • Twitter Policy
  • Terms of Use
social media iconTwitter social media iconLinkedin
MENU
  • About
    • About Us
    • Management Team
    • Board of Directors
    • Timeline
  • Pipeline
    • Overview
    • Hepatitis C Virus
    • Hepatitis B Virus
    • Respiratory Syncytial Virus
    • SARS-CoV-2
    • Human Metapneumovirus
  • Science
    • Overview
    • Publications
  • Patients
    • Overview
    • Clinical Trials
    • Expanded Access Policy
    • Resources
  • Careers
    • Join Us
    • Culture
    • Core Values
    • Testimonials
    • Benefits
  • Collaborations
    • Partnering
    • Out-Licensing
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
      • 2023 Annual Meeting
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Financials
      • Quarterly Results
      • Annual Reports
      • SEC Filings
    • ESG
      • Overview
      • Environmental
      • Social
      • Governance
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • RSS Feeds
  • Contact Us